Oncocross Co.,Ltd.
AI-powered biotech accelerating drug development for cancer and rare diseases.
382150 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 법원로11길 7 905호(문정동, 문정현대지식산업센터1-2), 서울특별시
- Website:
- https://www.oncocross.com/en
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Oncocross Co., Ltd. is an AI-powered biotechnology company focused on innovating the drug development process. The company leverages its proprietary AI platforms, such as RAPTOR AI™, to analyze an extensive, medically curated transcriptome database of patient, drug, and disease gene expression data. This technology-driven approach enables the identification of optimal drug-disease indications, facilitates drug repositioning to discover new therapeutic uses, and aims to reduce the time, cost, and failure rates of clinical trials. Oncocross concentrates on developing treatments for intractable conditions, including cancers and rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.2 MB | ||
| 2025-07-25 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시) (제1회차 CB)
|
Korean | 5.6 KB | ||
| 2025-07-22 00:00 |
Share Issue/Capital Change
기타경영사항(자율공시) (상장주관사의 신주인수권행사)
|
Korean | 8.7 KB | ||
| 2025-07-21 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 77.3 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.0 MB | ||
| 2025-04-25 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 355.0 KB | ||
| 2025-04-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 30.5 KB | ||
| 2025-04-15 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 15.9 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-04 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 366.6 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 23.0 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.9 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 26.3 KB | ||
| 2025-03-20 00:00 |
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
|
Korean | 457.5 KB | ||
| 2025-03-13 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all Oncocross Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oncocross Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
